Duffy Blood Group, Chemokine Receptor (DARC) (N-Term) Peptide
DARC
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all DARC products
- DARC (Duffy Blood Group, Chemokine Receptor (DARC))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- LSPSTENSSQ LDFEDVWNSS YGVNDSFPDG DYGANLEAAA PCHSCNLLDD
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-DARC Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- DARC (Duffy Blood Group, Chemokine Receptor (DARC))
- Background
-
The protein encoded by this gene is a glycosylated membrane protein and a non-specific receptor for several chemokines. The encoded protein is the receptor for the human malarial parasites Plasmodium vivax and Plasmodium knowlesi. Polymorphisms in this gene are the basis of the Duffy blood group system. Two transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: DARC,ACKR1,FY,GPD,
Protein Size: 336 - Gene ID
- 2532
- NCBI Accession
- NP_002027
- UniProt
- Q16570
-
You are here:
